Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

RDEA119 and Sorafenib Combination Dose Escalation Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00785226
First received: November 4, 2008
Last updated: October 14, 2016
Last verified: October 2016